James William West

USPTO Granted Patents = 79 (Patent Applications = 27)

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 13 (Patent Applications = 11)

Average Co-Inventor Count = 5.0

ph-index = 22

Forward Citations = 1,235(Granted Patents)

Inventors with similar research interests:

Location History:

Seattle, WA (US) (1998 - 2012)
San Mateo, CA (US) (2015 - 2020)
Santa Barbara, CA (US) (2013 - 2021)
Bend, OR (US) (2003 - 2024)
South San Francisco, CA (US) (2019 - 2024)

Company Filing History:

47 out of 84

Cytomx Therapeutics, Inc.

University of California

Bristol-myers Squibb Compnay

patents

6. 3 out of 103

Cell Therapeutics, Inc.

9. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

79 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459999 - Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof (2025-11-04),

2. 12441799 - Activatable anti-CTLA-4 antibodies and uses thereof (2025-10-14),

3. 12209120 - Activatable anti-VEGF scFv (2025-01-28),

4. 12139816 - Protease-resistant systems for polypeptide display and methods of making and using thereof (2024-11-12),

5. 11952427 - Anti-CD40 antibodies and uses thereof (2024-04-09),

6. 11890354 - Activatable antibodies that bind epidermal growth factor receptor and methods thereof (2024-02-06),

7. 11753466 - Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof (2023-09-12),

8. 11548944 - Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof (2023-01-10),

9. 11548943 - Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof (2023-01-10),

10. 11472875 - Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof (2022-10-18),

11. 11306149 - Anti-CD40 antibodies and uses thereof (2022-04-19),

12. 11198864 - Protease-resistant systems for polypeptide display and methods of making and using thereof (2021-12-14),

13. 11174316 - Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof (2021-11-16),

14. 11161906 - Multispecific antibodies, multispecific activatable antibodies and methods of using the same (2021-11-02),

15. 11117968 - Activatable anti-CTLA-4 antibodies and uses thereof (2021-09-14),

Title: Spotlight on Inventor James William West

Introduction:

James William West is a prolific inventor based in Bend, Oregon, with an impressive portfolio of 52 patents to his name. His innovative spirit and dedication to cutting-edge research have led to groundbreaking inventions in the field of biotechnology and healthcare.

Latest Patents:

James William West's latest patents showcase his expertise in developing activatable antibodies targeting specific receptors for therapeutic, diagnostic, and prophylactic applications. One of his recent inventions includes "Activatable antibodies that bind epidermal growth factor receptor and methods thereof," which offer promising new treatment avenues for conditions related to the epidermal growth factor receptor. Additionally, his work on "Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof" demonstrates his commitment to advancing precision medicine through novel antibody-based therapies.

Career Highlights:

Throughout his career, James William West has made significant contributions to the field of biotechnology through his work at esteemed organizations such as CytomX Therapeutics, Inc. and the University of California. His innovative approach to research and development has not only resulted in numerous patents but has also paved the way for future advancements in the healthcare industry.

Collaborations:

James William West has collaborated with talented individuals like Jason Gary Sagert and Nancy Elizabeth Stagliano, who have played crucial roles in bringing his inventions to fruition. Their combined expertise and shared vision for improving patient outcomes have led to successful partnerships and groundbreaking discoveries in the field of biotechnology.

Conclusion:

Inventor James William West's dedication to innovation and his remarkable track record of patenting cutting-edge technologies underscore his status as a trailblazer in the field of biotechnology. His work continues to inspire future generations of inventors and researchers, shaping the landscape of healthcare and biotechnology for years to come.

This text is generated by artificial intelligence and may not be accurate.